Search

Your search keyword '"Starck C"' showing total 419 results
Start Over Author "Starck C"

Refine your results

more »

more »

more »

more »

more »
419 results on '"Starck C"'

5. HRS-Expertenkonsensus (2017) Sondenmanagement und -extraktion von kardialen elektronischen Implantaten sowie EHRA-Expertenkonsensus (2018) zur wissenschaftlichen Aufarbeitung von Sondenextraktionen: Kommentar der AG Herzrhythmusstörungen der Deutschen Gesellschaft für Thorax‑, Herz- und Gefäßchirurgie

Author

Starck, C. T., Burger, H., Osswald, B., Hakmi, S., Knaut, M., Bimmel, D., Bärsch, V., Eitz, T., Mierzwa, M., Ghaffari, N., and Siebel, A.

Published
2021
Full Text
View/download PDF

6. Postinfarction Ventricular Septal Defect—Searching for the Optimal Solution.

Author

Kaemmel, J., Pasic, M., Wert, L., Pitts, L., Knosalla, C., Düsterhöft, V., Buz, S., Stamm, C., Kempfert, J., Starck, C., Jacobs, S., and Falk, V.

Subjects
VENTRICULAR septal defects, ARTIFICIAL blood circulation
Abstract

This article discusses the surgical treatment of postinfarction ventricular septal defect (VSD) and its high mortality rate. The study analyzed data from 46 patients treated at a single institution over a 10-year period. The primary endpoint of the study was 1-year survival, and the results showed a 50% survival rate for the whole group. The study suggests that beating-heart techniques should be considered to avoid additional myocardial ischemia. [Extracted from the article]

Published
2024
Full Text
View/download PDF

12. Defibrillator generator replacements in patients with left ventricular assist device support: The risks of hematoma and infection

Author

Eulert-Grehn, JJ, primary, Sterner, I, additional, Schoenrath, F, additional, Stein, J, additional, Mulzer, J, additional, Kurz, S, additional, Lanmüller, P, additional, Barthel, F, additional, Unbehaun, A, additional, Klein, C, additional, Jacobs, S, additional, Falk, V,, additional, Potapov, E, additional, and Starck, C, additional

Published
2022
Full Text
View/download PDF

13. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Author

Blomstrom-Lundqvist, C, Traykov, V, Erba, P, Burri, H, Nielsen, J, Bongiorni, M, Poole, J, Boriani, G, Costa, R, Deharo, J, Epstein, L, Saghy, L, Snygg-Martin, U, Starck, C, Tascini, C, Strathmore, N, Blomstrom-Lundqvist C., Traykov V., Erba P. A., Burri H., Nielsen J. C., Bongiorni M. G., Poole J., Boriani G., Costa R., Deharo J. -C., Epstein L. M., Saghy L., Snygg-Martin U., Starck C., Tascini C., Strathmore N., Blomstrom-Lundqvist, C, Traykov, V, Erba, P, Burri, H, Nielsen, J, Bongiorni, M, Poole, J, Boriani, G, Costa, R, Deharo, J, Epstein, L, Saghy, L, Snygg-Martin, U, Starck, C, Tascini, C, Strathmore, N, Blomstrom-Lundqvist C., Traykov V., Erba P. A., Burri H., Nielsen J. C., Bongiorni M. G., Poole J., Boriani G., Costa R., Deharo J. -C., Epstein L. M., Saghy L., Snygg-Martin U., Starck C., Tascini C., and Strathmore N.

Abstract

Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy devices are potentially lifesaving treatments for a number of cardiac conditions but are not without risk. Most concerning is the risk of a cardiac implantable electronic device (CIED) infection, which is associated with significant morbidity, increased hospitalizations, reduced survival, and increased health care costs. Recommended preventive strategies such as administration of intravenous antibiotics before implantation are well-recognized. Uncertainties have remained about the role of various preventive, diagnostic, and treatment measures such as skin antiseptics, pocket antibiotic solutions, antibacterial envelopes, prolonged antibiotics post-implantation, and others. When compared with previous guidelines or consensus statements, the present consensus document gives guidance on the use of novel device alternatives, novel oral anticoagulants, antibacterial envelopes, prolonged antibiotics post-implantation, as well as definitions on minimum quality requirements for centres and operators and volumes. The recognition that an international consensus document focused on management of CIED infections is lacking, the dissemination of results from new important randomized trials focusing on prevention of CIED infections, and observed divergences in managing device-related infections as found in an European Heart Rhythm Association worldwide survey, provided a strong incentive for a Novel 2019 International State-of-the-art Consensus document on risk assessment, prevention, diagnosis, and treatment of CIED infections.

Published
2020

14. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections—endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Author

Blomstrom-Lundqvist, C., Traykov, V., Erba, P. A., Burri, H., Nielsen, J. C., Bongiorni, M. G., Poole, J., Boriani, G., Costa, R., Deharo, J. -C., Epstein, L. M., Saghy, L., Snygg-Martin, U., Starck, C., Tascini, C., Strathmore, N., Kalarus, Z., Boveda, S., Dagres, N., Rinaldi, C. A., Biffi, M., Geller, L., Sokal, A., Birgersdotter-Green, U., Lever, N., Tajstra, M., Kutarski, A., Rodriguez, D. A., Hasse, B., Zinkernagel, A., Mangoni, E., Uppsala Universitet [Uppsala], Tokuda Hospital Sofia, University of Pisa - Università di Pisa, University Medical Center Groningen [Groningen] (UMCG), Aarhus University Hospital, Biorobotics Lab (University of Washington), University of Washington [Seattle], Università degli Studi di Modena e Reggio Emilia, Universidade Paulista [São Paulo] (UNIP), Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Département de Cardiologie [Hôpital de la Timone - APHM], Hôpital de la Timone [CHU - APHM] (TIMONE)-Assistance Publique - Hôpitaux de Marseille (APHM), Hofstra University [Hempstead], University of Szeged [Szeged], Department of Image Processing and Computer Graphics [Univ Szeged], University of Gothenburg (GU), West German Heart Center, Universität Duisburg-Essen [Essen], University Parthenope of Naples, The Royal Melbourne Hospital, Clinical sciences, Università degli Studi di Modena e Reggio Emilia = University of Modena and Reggio Emilia (UNIMORE), Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Universität Duisburg-Essen = University of Duisburg-Essen [Essen], Università degli Studi di Napoli 'Parthenope' = University of Naples (PARTHENOPE), Blomstrom-Lundqvist, C, Traykov, V, Erba, P, Burri, H, Nielsen, J, Bongiorni, M, Poole, J, Boriani, G, Costa, R, Deharo, J, Epstein, L, Saghy, L, Snygg-Martin, U, Starck, C, Tascini, C, Strathmore, N, Kalarus, Z, Boveda, S, Dagres, N, Rinaldi, C, Biffi, M, Geller, L, Sokal, A, Birgersdotter-Green, U, Lever, N, Tajstra, M, Kutarski, A, Rodriguez, D, Hasse, B, Zinkernagel, A, and Mangoni, E

Subjects
Leads, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Extraction, 030204 cardiovascular system & hematology, law.invention, Defibrillator, 0302 clinical medicine, Randomized controlled trial, law, Health care, Cardiac and Cardiovascular Systems, Endocarditi, 03.02. Klinikai orvostan, 030212 general & internal medicine, Antibiotic prophylaxis, Cardiac resynchronization therapy, Device, Pacemaker, Infection, Kardiologi, Re-implantation, Endocarditis, Latin America/epidemiology, Cardiac implantable electronic device, TRANSVENOUS LEAD EXTRACTION, Defibrillators, Implantable/adverse effects, Thoracic Surgery, General Medicine, STAPHYLOCOCCUS-AUREUS BACTEREMIA, F-18-FDG PET/CT, Defibrillators, Implantable, SINGLE-CENTER EXPERIENCE, 3. Good health, Cardiac implantable electronic devices, EHRA consensus document, Implantable cardioverter-defibrillators, Microbiology, Pacemakers, Cardiothoracic surgery, Risk assessment, Cardiology and Cardiovascular Medicine, EHRA Position Paper, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Asia, Consensus, PERMANENT PACEMAKER IMPLANTATION, CARDIOVERTER-DEFIBRILLATOR IMPLANTATION, Infections, Communicable Diseases, Implantable cardioverter-defibrillator, 03 medical and health sciences, LONG-TERM COMPLICATIONS, ANTIBIOTIC-PROPHYLAXIS, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Infections/diagnosis, Physiology (medical), medicine, Humans, Intensive care medicine, SURGICAL-SITE, business.industry, Cardiac Resynchronization Therapy Devices, Latin America, Lead, RISK-FACTORS, Artificial cardiac pacemaker, Surgery, Electronics, Implantable cardioverterdefibrillators, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Abstract

Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy devices are potentially life-saving treatments for a number of cardiac conditions, but are not without risk. Most concerning is the risk of a cardiac implantable electronic device (CIED) infection, which is associated with significant morbidity, increased hospitalizations, reduced survival, and increased healthcare costs. Recommended preventive strategies such as administration of intravenous antibiotics before implantation are well recognized. Uncertainties have remained about the role of various preventive, diagnostic, and treatment measures such as skin antiseptics, pocket antibiotic solutions, anti-bacterial envelopes, prolonged antibiotics post-implantation, and others. Guidance on whether to use novel device alternatives expected to be less prone to infections and novel oral anticoagulants is also limited, as are definitions on minimum quality requirements for centres and operators and volumes. Moreover, an international consensus document on management of CIED infections is lacking. The recognition of these issues, the dissemination of results from important randomized trials focusing on prevention of CIED infections, and observed divergences in managing device-related infections as found in an European Heart Rhythm Association worldwide survey, provided a strong incentive for a 2019 International State-of-the-art Consensus document on risk assessment, prevention, diagnosis, and treatment of CIED infections. This article is simultaneously published also in Eur J Cardiothorac Surg. (https://doi.org/10.1093/ejcts/ezz296) and European Heart Journal (https://doi.org/10.1093/eurheartj/ehaa010). Minor differences in style may appear in each publication, but the article is substantially the same in each journal.

Published
2019

16. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

Author

Glikson, M., Nielsen, J. C., Kronborg, M. B., Michowitz, Y., Auricchio, A., Barbash, I. M., Barrabes, J. A., Boriani, G., Braunschweig, F., Brignole, M., Burri, H., Coats, A. J. S., Deharo, J. -C., Delgado, V., Diller, G. -P., Israel, C. W., Keren, A., Knops, R. E., Kotecha, D., Leclercq, C., Merkely, B., Starck, C., Thylen, I., Tolosana, J. M., Leyva, F., Linde, C., Abdelhamid, M., Aboyans, V., Arbelo, E., Asteggiano, R., Baron-Esquivias, G., Bauersachs, J., Biffi, M., Birgersdotter-Green, U., Bongiorni, M. G., Borger, M. A., Celutkiene, J., Cikes, M., Daubert, J. -C., Drossart, I., Ellenbogen, K., Elliott, P. M., Fabritz, L., Falk, V., Fauchier, L., Fernandez-Aviles, F., Foldager, D., Gadler, F., De Vinuesa, P. G. G., Gorenek, B., Guerra, J. M., Hermann Haugaa, K., Hendriks, J., Kahan, T., Katus, H. A., Konradi, A., Koskinas, K. C., Law, H., Lewis, B. S., Linker, N. J., Lochen, M. -L., Lumens, J., Mascherbauer, J., Mullens, W., Nagy, K. V., Prescott, E., Raatikainen, P., Rakisheva, A., Reichlin, T., Ricci, R. P., Shlyakhto, E., Sitges, M., Sousa-Uva, M., Sutton, R., Suwalski, P., Svendsen, J. H., Touyz, R. M., Van Gelder, I. C., Vernooy, K., Waltenberger, J., Whinnett, Z., Witte, K. K., Qoriany, A., Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), and Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)

Subjects
Pacemaker, Artificial, Cardiac pacing, medicine.medical_treatment, [SDV]Life Sciences [q-bio], Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], cardiac resynchronization therapy, heart failure, temporary pacing, law.invention, law, atrial fibrillation, 610 Medicine & health, ComputingMilieux_MISCELLANEOUS, biology, Cardiac Pacing, Artificial, Syncope (genus), Atrial fibrillation, syncope, Cardiology, cardiovascular system, medicine.symptom, guidelines, cardiac pacing, pacemaker, conduction system pacing, pacing indications, alternate site pacing, complications, pacing in TAVI, bradycardia, Cardiology and Cardiovascular Medicine, Bradycardia, medicine.medical_specialty, Cardiac resynchronization therapy, Guidelines, Physiology (medical), Internal medicine, medicine, Humans, Task force, business.industry, Stroke Volume, 1103 Clinical Sciences, medicine.disease, biology.organism_classification, Heart Rhythm, Cardiovascular System & Hematology, Heart failure, Artificial cardiac pacemaker, business, Atrioventricular block
Abstract

These are the clinical practice guidelines of the European Society of Cardiology on cardiac pacing and cardiac resynchronization therapy, from 2021.

Published
2022
Full Text
View/download PDF

24. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA)

Author

Glikson, M., Nielsen, J.C., Kronborg, M.B., Michowitz, Y., Auricchio, A., Barbash, I.M., Barrabes, J.A., Boriani, G., Braunschweig, F., Brignole, M., Burri, H., Coats, A.J.S., Deharo, J.C., Delgado, V., Diller, G.P., Israel, C.W., Keren, A., Knops, R.E., Kotecha, D., Leclercq, C., Merkely, B., Starck, C., Thylen, I., Tolosana, J.M., European Soc Cardiology ESC, European Heart Rhythm Assoc EHRA, and ESC Sci Document Grp

Subjects
complications, cardiac pacing, alternate site pacing, cardiac resynchronization therapy, heart failure, Guidelines, bradycardia, pacemaker, temporary pacing, pacing indications, syncope, conduction system pacing, atrial fibrillation, pacing in TAVI
Published
2021

25. Clinical practice and implementation of guidelines for the prevention, diagnosis and management of cardiac implantable electronic device infections: results of a worldwide survey under the auspices of the European Heart Rhythm Association

Author

Traykov, V, Bongiorni, M, Boriani, G, Burri, H, Costa, R, Dagres, N, Deharo, J, Epstein, L, Erba, P, Snygg-Martin, U, Nielsen, J, Poole, J, Saghy, L, Starck, C, Strathmore, N, Blomstrom-Lundqvist, C, Traykov V., Bongiorni M. G., Boriani G., Burri H., Costa R., Dagres N., Deharo J. -C., Epstein L. M., Erba P. A., Snygg-Martin U., Nielsen J. C., Poole J. E., Saghy L., Starck C., Strathmore N., Blomstrom-Lundqvist C., Traykov, V, Bongiorni, M, Boriani, G, Burri, H, Costa, R, Dagres, N, Deharo, J, Epstein, L, Erba, P, Snygg-Martin, U, Nielsen, J, Poole, J, Saghy, L, Starck, C, Strathmore, N, Blomstrom-Lundqvist, C, Traykov V., Bongiorni M. G., Boriani G., Burri H., Costa R., Dagres N., Deharo J. -C., Epstein L. M., Erba P. A., Snygg-Martin U., Nielsen J. C., Poole J. E., Saghy L., Starck C., Strathmore N., and Blomstrom-Lundqvist C.

Abstract

AIMS: Cardiac implantable electronic device (CIED) infection rates are increasing. Worldwide compliance and disparities to published guidelines for the prevention, diagnosis and management of these conditions are not well elucidated. The purpose of this survey, therefore, was to clarify these issues through an inquiry to arrhythmia-related associations and societies worldwide. METHODS AND RESULTS: A questionnaire comprising 15 questions related to CIED infections was distributed among members of seven arrhythmia societies worldwide. A total of 234 centres in 62 countries reported implantation rates of which 159 (68.0%) performed more than 200 device implantations per year and 14 (6.0%) performed fewer than 50 implantations per year. The reported rates of CIED infections for 2017 were ≤2% in 78.7% of the centres, while the infection rates exceeded 5% in 7.8% of the centres. Preventive measures for CIED infection differed from published recommendations and varied among different regions mainly in terms of pocket irrigation and administering post-operative antimicrobial therapy the use of which was reported by 39.9% and 44% of the respondents, respectively. Antibacterial envelopes were used by 37.7% of the respondents in selected circumstances. In terms of pocket infection management, 62% of the respondents applied complete system removal as an initial step. Diagnostic pocket needle aspiration and pocket surgical debridement were reported by 15.8% and 11.8% of centres, respectively. CONCLUSION: Clinical practices for prevention and management of CIED do not fully comply with current recommendations and demonstrate considerable regional disparities. Further education and programmes for improved implementation of guidelines are mandatory.

Published
2019

28. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

Author

Glikson, M., Nielsen, J.C., Kronborg, M.B., Michowitz, Y., Auricchio, A., Barbash, I.M., Barrabés, J.A., Boriani, G., Braunschweig, F., Brignole, M., Burri, H., Coats, A.J.S., Deharo, J.C., Delgado, V., Diller, G.P., Israel, C.W., Keren, A., Knops, R.E., Kotecha, D., Leclercq, C., Merkely, B., Starck, C., Vernooy, K., Thylén, I., Tolosana, J.M., Glikson, M., Nielsen, J.C., Kronborg, M.B., Michowitz, Y., Auricchio, A., Barbash, I.M., Barrabés, J.A., Boriani, G., Braunschweig, F., Brignole, M., Burri, H., Coats, A.J.S., Deharo, J.C., Delgado, V., Diller, G.P., Israel, C.W., Keren, A., Knops, R.E., Kotecha, D., Leclercq, C., Merkely, B., Starck, C., Vernooy, K., Thylén, I., and Tolosana, J.M.

Abstract

Contains fulltext : 239015.pdf (Publisher’s version ) (Closed access)

Published
2021

29. EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS)

Author

Burri, H., Starck, C., Auricchio, A., Biffi, M., Burri, M., D'Avila, A., Deharo, J.C., Glikson, M., Israel, C., Lau, C.P., Leclercq, C., Love, C.J., Nielsen, J.C., Vernooy, K., Dagres, N., Boveda, S., Butter, C., Marijon, E., Braunschweig, F., Mairesse, G.H., Gleva, M., Defaye, P., Zanon, F., Lopez-Cabanillas, N., Guerra, J.M., Vassilikos, V.P., Martins Oliveira, M., Burri, H., Starck, C., Auricchio, A., Biffi, M., Burri, M., D'Avila, A., Deharo, J.C., Glikson, M., Israel, C., Lau, C.P., Leclercq, C., Love, C.J., Nielsen, J.C., Vernooy, K., Dagres, N., Boveda, S., Butter, C., Marijon, E., Braunschweig, F., Mairesse, G.H., Gleva, M., Defaye, P., Zanon, F., Lopez-Cabanillas, N., Guerra, J.M., Vassilikos, V.P., and Martins Oliveira, M.

Abstract

Contains fulltext : 238765.pdf (Publisher’s version ) (Closed access), With the global increase in device implantations, there is a growing need to train physicians to implant pacemakers and implantable cardioverter-defibrillators. Although there are international recommendations for device indications and programming, there is no consensus to date regarding implantation technique. This document is founded on a systematic literature search and review, and on consensus from an international task force. It aims to fill the gap by setting standards for device implantation.

Published
2021

40. Impact de la densité du PSA et de l’IRM multiparamétrique dans l’indication à une surveillance active d’un adénocarcinome prostatique à faible risque

Author

Saout, K., primary, Zambon, A., additional, N’Guyen, T., additional, Lucas, C., additional, Payrard-Starck, C., additional, Marolleau, J., additional, Segalen, T., additional, Tissot, V., additional, Doucet, L., additional, Deruelle, C., additional, Joulin, V., additional, Fourcade, A., additional, Fournier, G., additional, and Valeri, A., additional

Published
2020
Full Text
View/download PDF

45. Acute and Midterm Results after AMDS (Ascyrus Medical Dissection Stent) Implantation for Arch Remodeling in the Treatment of Acute DeBakey-I Dissections: A Prospective International Trial

Author

Heck, R., additional, Montagner, M., additional, Bozso, S. J., additional, Nagendran, J., additional, Chu, M. W., additional, El-Hamamsy, I., additional, Ouzounian, M., additional, Kempfert, J., additional, Starck, C., additional, and Moon, M. C., additional

Published
2020
Full Text
View/download PDF

48. Einsatz der extra - korpo ralen Zirkulation (ECLS / ECMO) bei Herz-und Kreislaufversagen.

Author

Boeken, U., Ensminger, S., Assmann, A., Schmid, C., Werdan, K., Michels, G., Miera, O., Schmidt, F., Klotz, S., Starck, C., Pilarczyk, K., Rastan, A., Burckhardt, M., Nothacker, M., Muellenbach, R., Zausig, Y., Haake, N., Groesdonk, H., Ferrari, M., and Buerke, M.

Abstract

Copyright of Anaesthesiologie & Intensivmedizin is the property of DGAI e.V. - Deutsche Gesellschaft fur Anasthesiologie und Intensivmedizin e.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2021

50. Direct measurement of lateral elastic modulations in a zero-net strained GaInAsP/InP multilayer

Author

Ponchet, A., Rocher, A., Emery, J.-Y., Starck, C., and Goldstein, L.

Subjects
Gallium compounds -- Research, Stress analysis (Engineering) -- Research, Physics
Abstract

Nonhomogeneous elastic modulation occurs in all the layers of a zero-net strained GaIn AsP/InP (001) multilayer prepared by gas source molecular beam epitaxy. The modulation includes orthorhombic modulated distortion and large interfacial undulations. These changes are caused by elastic relaxation occurring in the tensile layers. The elastic strain in GaInAsP/InP (001) multilayer occurs along the (110) oriented plane.

Published
1995

Catalog

Books, media, physical & digital resources
See catalog results